MTOR and breast carcinoma: To date, many therapeutic targets have been verified for treating breast cancers, including CDK4/6 inhibitors, HDAC inhibitor, Estrogen pathway antagonists, VEGF inhibitors, PI3K inhibitors, mTOR inhibitors, etc.6–8.